Abstract
Objective
Dopamine transporter single-photon emission computed tomography (DAT SPECT) has been widely used to diagnose Parkinson syndrome. Using the standardized uptake value (SUV) of DAT SPECT, we propose “functional dopamine transporter volume (f-DTV)” as a new quantitative index to evaluate the three-dimensional volume of functional dopamine transporters and assess its diagnostic ability in differentiating dopaminergic neurodegenerative diseases (dNDD) from non-dNDD.
Methods
Seventy-nine patients were enrolled (42 dNDD, 37 non-dNDD; 38 men; age 24–88 years). We analyzed seven quantitative indices. The specific binding ratio (SBR) was calculated using a program specialized for DAT SPECT (SBR_Bolt). The SUVmax, SUVpeak, and SUVmean were calculated using a quantification program for bone SPECT. SBR_SUV was calculated by dividing striatal SUVmean by the average of background SUVmean. The cutoff value of the active dopamine transporter level was examined using three methods (threshold of 40% of SUVmax, SUV 2, and SUV 3) to calculate the active dopamine transporter volume (ADV). The f-DTV was calculated by multiplying ADV and SUVmean. We assessed the correlations between SBR_Bolt and SBR_SUV, and compared the mean value of each index between the dNDD and non-dNDD groups. The abilities of SBR_Bolt, SBR_SUV, SUVmax, SUVpeak, SUVmean, ADV, and f-DTV in differentiating dNDD from non-dNDD were determined by the area under the receiver operating curve (AUC) generated by the receiver operating characteristics analysis.
Results
The SBR_Bolt and SBR_SUV highly correlated with each other (r = 0.71). The cutoff value of the active dopamine transporter level was determined as SUV 3. All seven quantitative indices showed lower values in the dNDD group than in the non-dNDD group, and the difference between the two groups was statistically significant (p < 0.05). Sensitivity, specificity, and AUC of f-DTV were slightly lower than those of SBR_Bolt (71%, 79%, and 0.81, respectively, for f-DTV, and 81%, 84%, 0.88, respectively, for SBR_Bolt). The difference in AUC between f-DTV and SBR_Bolt was not statistically significant.
Conclusions
This study demonstrates the utility of f-DTV as a novel quantitative index for evaluating the three-dimensional volume of functional dopamine transporters, and that f-DTV has almost the same diagnostic ability to differentiate dNDD from non-dNDD using DAT SPECT.
Similar content being viewed by others
References
Uyama N, Otsuka H, Shinya T, Otomi Y, Harada M, Sako W, et al. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes. Nucl Med Commun. 2017;38:487–92. https://doi.org/10.1097/MNM.0000000000000674.
Kägi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81(1):5–12. https://doi.org/10.1136/jnnp.2008.157370.
Varrone A, Halldin C. Molecular imaging of the dopamine transporter. J Nucl Med. 2010;51(9):1331–4. https://doi.org/10.2967/jnumed.109.065656.
JSNM (Japanese Society of Nuclear Medicine). Clinical practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT ver.2 JSNM 2017
Ueda J, Yoshimura H, Shimizu K, Hino M, Kohara N. Combined visual and semi-quantitative assessment of (123)I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases. Neurol Sci. 2017;38:1187–91. https://doi.org/10.1007/s10072-017-2936-3.
Davidsson A, Georgiopoulos C, Dizdar N, Granerus G, Zachrisson H. Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson’s disease and atypical Parkinsonian syndromes using DaTSCAN® SPECT. Ann Nucl Med. 2014;28:851–9. https://doi.org/10.1007/s12149-014-0878-x.
Nicastro N, Garibotto V, Allali G, Assal F, Burkhard PR. Added value of combined semi-quantitative and visual [123I]FP-CIT SPECT analyses for the diagnosis of dementia with Lewy bodies. Clin Nucl Med. 2017;42:e96–102. https://doi.org/10.1097/RLU.0000000000001477.
Mäkinen E, Joutsa J, Johansson J, Mäki M, Seppänen M, Kaasinen V. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism. J Neural Transm. 2016;123:1309–18. https://doi.org/10.1007/s00702-016-1586-6.1.
Tossici-Bolt L, Hoffmann S, Kemp P, Mehta R, Fleming J. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. EurJ Nucl Med Mol Iaging. 2006;33:1491–9. https://doi.org/10.1007/s00259-006-0155-x.
Kaira K, Higuchi T, Naruse I. Metabolic activity by (18)F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC. Eur J Nucl Med Mol Imaging. 2018;45:56–66. https://doi.org/10.1007/s00259-017-3806-1.
Wei H, Weihao Z, Jiadong X, Hacker M, Bertling J, Lewis R, et al. Standardized uptake values of 99mTc-MDP SPECT bone scans - a novel method for absolute SPECT/CT quantification. J Nucl Med 2015;56(Suppl 3):1790
Kuji I, Yamane T, Seto A, Yasumizu Y, Shirotake S, Oyama M. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer. Eur J Hybrid Imaging. 2017;1:2. https://doi.org/10.1186/s41824-017-0006-y.
Toriihara A, Daisaki H, Yamaguchi A, Kobayashi M, Furukawa S, Yoshida K, et al. Semiquantitative analysis using standardized uptake value in 123I-FP-CIT SPECT/CT. Clin Imaging. 2018;52:57–61. https://doi.org/10.1016/j.clinimag.2018.06.009.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–4. https://doi.org/10.1136/jnnp.55.3.181.
Catafau AM, Tolosa E. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord. 2004;19:1175–82. https://doi.org/10.1002/mds.20112.
Spiegel J, Hellwig D, Samnick S, Jost W, Möllers MO, Fassbender K, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease. J Neural Transm. 2007;114:331–5. https://doi.org/10.1007/s00702-006-0518-2.
Bieńkiewicz M, Górska-Chrzastek M, Siennicki J, Gajos A, Bogucki A, Mochecka-Thoelke A, et al. Impact of CT based attenuation correction on quantitative assessment of DaTSCAN ((123)I-Ioflupane) imaging in diagnosis of extrapyramidal diseases. Nucl Med Rev Cent East Eur. 2008;11:53–8.
Miyai M, Yamamoto Y, Uchibe T, Yada N, Haramoto M, Katsube T, et al. Comparison of quantitative value of dopamine transporter scintigraphy calculated from different analytical software. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015;71:1209–14. https://doi.org/10.6009/jjrt.2015_JSRT_71.12.1209 ([Article in Japanese]).
Tossici-Bolt L, Dickson JC, Sera T, Nijs R, Bagnara MC, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 2011;38:1529–40. https://doi.org/10.1007/s00259-011-1801-5 (Epub 2011 Apr 6).
Tossici-Bolt L, Dickson JC, Sera T, Booij J, Asenbaun-Nan S, Bagnara MC, Borght TV, et al. [123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods. EJNMMI Phys. 2017;4:8. https://doi.org/10.1186/s40658-017-0175-6 (Epub 2017 Jan 28).
Kameiyama H, Matsutomo N, Nagaki A, Fusae YF. Effect of reconstruction strategies for the quantification and diagnostic accuracy of (123)I-FP-CIT SPECT. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2016;72:595–601. https://doi.org/10.6009/jjrt.2016_JSRT_72.7.595 (Article in Japanese).
Rahman MGM, Islam MM, Tsujikawa T, Kiyono Y, Okazawa H. Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis. Ann Nucl Med. 2019;33:14–21. https://doi.org/10.1007/s12149-018-1297-1 (Epub 2018 Oct 1).
Iwabuchi Y, Nakahara T, Kameyama M, Yamada Y, Hashimoto M, Ogata Y, et al. Quantitative evaluation of the tracer distribution in dopamine transporter SPECT for objective interpretation. Ann Nucl Med. 2018;32:363–71. https://doi.org/10.1007/s12149-018-1256-x (Epub 2018 Apr 13).
Iwabuchi Y, Nakahara T, Kameyama M, Yamada Y, Hashimoto M, Matsusaka Y, et al. Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings. EJNMMI Res. 2019;9:7. https://doi.org/10.1186/s13550-019-0477-x.
Wakabayashi Y, Takahashi R, Kanda T, Zeng F, Nogami M, Ishii K, et al. Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in 123I-FP-CIT single-photon emission computed tomography (DaTscan). Neurol Sci. 2018;39:1401–7. https://doi.org/10.1007/s10072-018-3437-8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bando, R., Otsuka, H., Otani, T. et al. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography. Ann Nucl Med 35, 504–513 (2021). https://doi.org/10.1007/s12149-021-01592-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-021-01592-w